On-target and Off-Target Effects Associated with CRISPR/Cas Technique

Dr. MATTHIAS SCHRÖDER 

Course Co-director

PhD in Immunology at the Division of Immunopharmacology of the University Clinic of Frankfurt am Main. Involved in basic and applied research for immunological interventions to treat cancer for 13 years. Currently involved in the development of fusion proteins to activate receptors of the TNF-superfamily (CD40, CD27 etc.) at a small German Biotech company as Head of Assay Development.